KRAVICZ MARCELO HENRIQUE

Amenta, A., Comi, S., Kravicz, M., Sesana, S., Antoniou, A., Passarella, D., et al. (2025). A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy. RSC MEDICINAL CHEMISTRY, 16(1), 168-178 [10.1039/d4md00517a]. Dettaglio

Iannone, M., Kravicz, M., Rainone, P., Antoniou, A., Stucchi, S., Valtorta, S., et al. (2025). Automated fluorine-18 radiolabeling via an alkyne–azide cycloaddition reaction on a dual peptide-functionalized liposome surface for in vivo PET imaging. FRONTIERS IN PHARMACOLOGY, 16 [10.3389/fphar.2025.1566257]. Dettaglio

Persico, A., Molteni, L., Mantecca, P., Kravicz, M., Bragato, C. (2025). Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system. SCIENTIFIC REPORTS, 15(1) [10.1038/s41598-025-00258-1]. Dettaglio

Sierri, G., Patrucco, M., Ferrario, D., Renda, A., Comi, S., Ciprandi, M., et al. (2024). Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine. WILEY INTERDISCIPLINARY REVIEWS. NANOMEDICINE AND NANOBIOTECHNOLOGY, 16(5 (September/October 2024)) [10.1002/wnan.1991]. Dettaglio

Kravicz, M., Taiarol, L., Viegas, J., Sierri, G., Mauri, M., Koch, M., et al. (2024). Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 101(Part A November 2024) [10.1016/j.jddst.2024.106238]. Dettaglio